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Breast cysts occur frequently in premenopausal women. Gross
cystic breast disease (GCBD), defined as the presence of cysts
more than 1 cm in diameter, is a common condition, affecting
7–10% of women in the Western world (Haagensen et al, 1981).
There are two types of breast cysts. Type I have an apocrine
epithelium and are filled with breast cyst fluid (BCF) that has a
Na+/K+ ratio < 3, high concentration of steroid sulphates and a low
albumin concentration (Miller et al, 1983). In contrast, Type II
cysts are lined by a flattened epithelium and their BCF has a
Na+/K+ ratio > 3, low steroid sulphate levels but a high albumin
concentration (Sanchez et al, 1992; Duncan et al, 1994a). Women
with breast cysts are generally considered to have an increased risk
of breast cancer (Dixon et al, 1985, 1999; Bodian et al, 1992).
Several investigations have found that there may be a higher risk
associated with Type I cysts (Bruzzi et al, 1997), but this was not
confirmed in a recent study (Dixon et al, 1999).
While there is evidence of an increased risk of breast cancer for
women with breast cysts for Western women, it is not yet known if
this association also applies to women from Eastern Europe. The
incidence of breast cancer is lower in this part of the world
(Armstrong and Doll, 1975). The incidence of GCBD may also be
lower in Eastern Europe although there is some evidence that its
incidence is increasing in Poland (Reed et al, 1994). This may
possibly reflect the socio-economic changes that are taking place
in that country.
Breast cysts are not themselves considered to be premalignant
lesions but it is possible that the fluid could influence hormone
synthesis or metabolism in breast tissues adjacent to the cyst. Such
a possibility has stimulated investigations to investigate the
biochemical composition of BCF and also to examine its ability to
modulate the actions of enzymes involved in oestrogen synthesis.
In addition to the presence of cations and steroid conjugates,
BCF contains many growth factors, cytokines and proteins (Lai et
al, 1990a; Reed et al, 1992). BCF, and some of the factors it
contains, have been found to stimulate the activities of two of the
key enzymes involved in oestrogen synthesis in breast cancer
epithelial cells and fibroblasts. Aromatase activity, the enzyme
responsible for the conversion of androstenedione to oestrone, is
stimulated by BCF (Reed et al, 1993). This finding led to the iden-
tification of the cytokines, interleukin-1 (IL-1) and IL-6, as being
important in regulating peripheral oestrogen synthesis. In addition,
IL-6 also stimulates the conversion of oestrone to the biologically
active oestrogen, oestradiol, in MCF-7 breast cancer cells (Duncan
et al, 1994b). This reaction is mediated by oestradiol 17b-
hydroxysteroid dehydrogenase Type I (E2DHI).
A third enzyme system is now considered to also have an
important role in regulating blood and tissue oestrogen concentra-
tions (Hobkirk, 1993). Much of the oestrone formed from
androstenedione is converted to oestrone sulphate (E1S) by
sulphotransferase enzymes. Several different sulphotransferases
are present in body tissues. While there is a specific oestrogen
sulphotransferase, the phenol form of phenolsulphotransferase is
thought to be responsible for E1S formation in breast cancer cells
(Falany et al, 1993). E1S is present at high concentration in BCF,
blood and in normal and malignant breast tissues (Pasqualini et al,
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gated oestrogen by oestrone sulphatase (E1-STS). The balance
between the formation of E1S and its hydrolysis will therefore
have a pivotal role in regulating the availability of unconjugated
oestrogens in cells and tissues. So far, however, few studies appear
to have compared the effects of regulatory factors on E1S forma-
tion and hydrolysis.
In the present investigation the ability of BCF obtained from
British and Hungarian women to modulate E1S formation and
hydrolysis has been compared in oestrogen receptor-positive
(ER+) and ER-negative (ER–) breast cancer cell lines. Such
studies might reveal important clues as to the reasons for the
differences in the incidence of breast cancer in British and
Hungarian women. In addition, by comparing the relative effects
of BCF on E1S formation and hydrolysis, further information
about the role of oestrogen sulphates in breast cancer may be forth-
coming.
MATERIALS AND METHODS
Sample collection
BCF samples were obtained by fine-needle aspiration from 17
patients (11 British and six Hungarian) attending breast clinics in
London and Budapest. Their informed consent to participate in the
investigations was obtained and the studies were approved by
Ethics Committees at the respective hospitals. Subjects were all
premenopausal and were not receiving endocrine therapy at the
time of BCF collection. Samples of BCF were centrifuged at 
1500 g for 10 min after collection to remove cell debris and the
supernatants stored at –20°C until assayed. Hungarian BCF
samples were transported to the UK on solid carbon dioxide. The
ability of BCF, when stored at –20°C, to modulate sulphatase or
sulphotransferase activities remained constant over a 12- to 18-
month period, indicating the stability of regulatory factor(s). Sodium
and potassium concentrations were measured by an indirect ion-
selective electrode (Beckman Electrolyte 2 Analyser). Type I and
Type II BCFs were identified by Na+/K+ ratios of < 3 or > 3.
Cell culture
MCF-7 (ER+) and MDA-MB-231 (ER–) breast cancer cells were
obtained from the American Type Culture Collection (Rockville,
MD, USA). They were routinely cultured in T25 flasks with Eagle’s
modified MEM with HEPES buffer (20 mM). This medium was
supplemented with L-glutamine (2 mM), sodium hydrogen
carbonate (10 mM), 1% non-essential amino acids, 5% (v/v) fetal
calf serum (FCS) and 1% antibiotics/antimycotics. Cells were
grown in this medium until approximately 40% confluent. Before
adding BCF, cells were washed with phosphate-buffered saline
(PBS). BCF was diluted 1:5 (v/v) with medium and sterilized by
filtration. During the treatment period cells were incubated in
phenol-red free medium, using the supplements as previously
described with the exception that 2% (v/v) stripped FCS was used.
Triplicate flasks were treated with diluted BCF for a 48-h period
after which medium was removed and intact cells were washed
thoroughly with PBS before being assayed for the formation or
hydrolysis of E1S. At the end of the assay period cell numbers
were determined using a Coulter counter. Preliminary experiments
confirmed that BCF diluted at up to 1:10 (v/v) stimulated E1-STS
activity in a dose-dependent manner (Purohit et al, 1996).
Assays for E1S formation and hydrolysis
The methods used to assay the hydrolysis (E1-STS) and formation
of E1S by MCF-7 and MDA-MB-231 cells have been previously
described and fully validated (Purohit and Reed, 1992; Purohit et
al, 1999). Briefly, for the assay of E1-STS activity [6,7- 3H] E1S
(2–3 nM, 7 ´ 105 dpm, NEN-DuPont) in serum-free medium was
added to cells after which they were incubated for 20 h at 37°C.
After incubation an aliquot of the medium was removed and the
extent of E1S hydrolysis determined by liquid partition with
toluene. [4-14C]Oestrone (Amersham International, Aylesbury,
Bucks, UK) was used to monitor procedural losses. For the assay
of oestrone sulphate formation a similar procedure was employed
with the exception that [6,7-3H] oestrone (1–2 nM, 1 ´ 105 dpm,
Amersham International) was used as the substrate.
Results were calculated as final product per 20 h per million
cells. Mean basal E1-STS activities (n = 3) in MCF-7 and MDA-
MB-231 cells were 27.8 and 180 fmol per 20 h per million cells
respectively. The corresponding values for E1S formation in the
ER+ and ER– cells were 114 and 72.5 fmol per 20 h per million
cells respectively. Because of some small variations in basal
activities in cells over the duration of these investigations results
have been expressed as percentage change from control cells.
Representative experiments were repeated to confirm that the
inter-assay variation was less than 10%. For the 48-h treatment
period some small changes (± 10%) in the growth of cells was
detected.
Partial characterization of factors in BCF
BCF (Type 1) from an English subject, for which the volume
exceeded 100 ml, was used to investigate the nature of the
factor(s) that was able to modulate E1S formation or hydrolysis.
For this, BCF (8 ml) was separated by 10 kDa cut-off membrane
centrifugation (Amicon, Stonehouse, Glos., UK) and the eluent
applied to a similar 3 kDa membrane, giving three fractions, i.e. 
> 10 kDa, 3–10 kDa and < 3 kDa. Each fraction was restored to 8
ml with cell culture medium and the effect on E1-STS activity in
MCF-7 cells was assayed as described. In addition, several small
chromatography columns (Superclean SPE, Sigma) were used,
with BCF (1 ml) being applied to each in conditions expected to
enhance binding (Solvent 1). The columns were then eluted with a
solvent expected to displace bound factors (Solvent 2). The
columns were cation and anion ion-exchange columns (LC-WCX
and LC-SAX, Solvent 1: 0.1 M sodium phosphate buffer pH 7.4,
Solvent 2: 0.1 M sodium phosphate buffer pH 7.4, 2 M sodium
chloride) and phenyl and C-18 reverse phase columns (LC-pH and
LC-18, Solvent 1: 0.1 M sodium phosphate buffer pH 7.4, Solvent
2: 80% acetonitrile, 0.1% trifluoroacetic acid). The bound and free
fractions were taken to dryness, reconstituted in cell culture
medium and their effect on E1-STS activity in MCF-7 cells
assayed. Samples from columns with no BCF applied were
assayed at the same time to control for solvent interference.
Statistics
The Mann–Whitney test was used to determine the significance of
differences in the ability of BCF from British or Hungarian women
to modulate E1S hydrolysis or formation. Linear regression
analysis was used to examine the relationships between Na+/K+
ratios and the extent of stimulation or inhibition of E1S formation
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RESULTS
BCFs collected from 11 British women with GCBD were initially
examined for their ability of influence E1-STS activity in MCF-7
or MDA-MB-231 breast cancer cells. BCF from these women was
found to modulate E1-STS activity in both cell types but in a reci-
procal manner. Of the 11 samples, one stimulated E1-STS activity
in the ER+ cells (12%) and inhibited activity in the ER– cells
(23%). The remaining samples inhibited E1-STS activity in MCF-
7 cells (18–52%) or stimulated activity in MDA-MB-231 cells
(3–94%). As shown in Figure 1A and 1B, the Na+/K+ ratio was
found to be related to the extent to which BCF inhibited or stimu-
lated E1-STS activity in the ER+ and ER– breast cancer cells. That
the effect did not result from the Na+/K+ concentrations in BCF
was confirmed by examining the effects of different concentra-
tions of these cations on enzyme activity. Medium in which the
Na+/K+ ratios were adjusted to 0.12 or 27.0 respectively had no
significant stimulatory or inhibitory effects on E1-STS (data not
shown). The ability of BCF from Hungarian women to modulate
E1S hydrolysis was also related to its Na+/K+ ratio (Figure 1A,
1B). Overall, there was no significant difference in the ability of
BCF from British (median –35%, range –52% to 12%) or
Hungarian women (median –28%, range –55% to 3%) to regulate
E1S hydrolysis in ER+ cells. Similarly, the degree of stimulation
in ER– cells (median values 36% and 19% respectively) did not
differ significantly. The reciprocal nature of the inhibition of E1-
STS in MCF-7 cells and stimulation in MDA-MB-231 cells for the
British and Hungarian samples was confirmed by correlation
analysis (Figure 2). There was a significant correlation (r = –0.57,
P < 0.02) between the extent of inhibition or stimulation in the
ER+ and ER– cells respectively.
Similar investigations were carried out to examine the effects of
BCF on E1S formation in MCF-7 and MDA-MB-231 breast
cancer cells. For the ER+ cells BCF from both British and
Hungarian women stimulated E1S formation (Figure 3A).
Stimulation of E1S formation tended to be higher by BCFs with
low Na+/K+ ratios. In MDA-MB-231 cells E1S formation was
inhibited by BCFs from both groups of women (Figure 3B). For
these cells, however, the electrolyte ratios of the samples did not
appear to influence the extent of inhibition. The extent of stimula-
tion of E1S formation by BCF from British women in ER+ 
cells (median = 82%, range 46–139%) was significantly greater 
(P < 0.01) than by BCF from Hungarian women (median 33%,
range 20–44%). Inhibition of E1S formation in ER– cells by BCF
from British women (median –56%, range –80% to –40%) than by
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Figure 1 Effect of breast cyst fluid from British (closed circles) or Hungarian (open circles) women on oestrone sulphatase activity in: (A) MCF-7 or (B) MDA-
MB-231 breast cancer cells. Results are expressed as the percentage change compared with control cells and related to the Na+/K+ ratio of the cyst fluid
Figure 2 Inverse correlation between the stimulation of oestrone
sulphatase activity in MDA-MB-231 and inhibition in MCF-7 breast cancer
cells by breast cyst fluid from British and Hungarian womenBCF from Hungarian women (median –42%, range –62% to 8%)
did not differ significantly.
The availability of unconjugated oestrogens to cells and tissues
is likely to be governed by the balance between E1S formation and
hydrolysis. The relative rates of its formation and hydrolysis in
control and treated ER+/– cells were therefore examined. For
untreated MCF-7 or MDA-MB-231 cells the ratios of E1S forma-
tion to hydrolysis were 4.1 and 0.4 respectively. This indicates that
formation of E1S predominates in ER+ cells. Treatment of cells
with BCF increased the ratio of E1S formation to hydrolysis from
4.1 to a mean value of 11.9 in MCF-7 cells. In contrast, for MDA-
MB-231 cells this ratio was reduced from 0.4 to 0.14. Thus the
factors present in BCF enhance E1S formation in ER+ cells while
reducing it is ER– cells.
The Type 1 BCF from an English subject used in the characteri-
zation experiments was inhibitory to E1-STS activity in MCF-7
cells before fractionation. The inhibitory activity recovered after
membrane centrifugation was distributed between 53% in the 
> 10 kDa fraction and 47% in the < 3 kDa fraction, with no activity
in the 3–10 kDa fraction. The inhibitory activity bound poorly to
the anion exchange column (89% of the recovered activity in the
unbound fraction versus 11% in the bound and subsequently eluted
fraction) but rather better to a cation exchange column (63%
bound vs 36% unbound). It also bound poorly to the hydrophobic
phenyl and C-18 columns (63% and 59% free respectively).
DISCUSSION
This study has revealed that BCF from British and Hungarian
women has the capacity to modulate the formation and hydrolysis
of E1S in breast cancer cells. These findings confirm the results of
previous preliminary investigations into the regulation of E1-STS
activity by BCF (Purohit et al, 1996; Erbas et al, 1996). Overall,
the abilities of BCF from British or Hungarian women to stimulate
or inhibit E1S hydrolysis were similar for a given Na+/K+ ratio. In
contrast, BCF from British women had a significantly greater
stimulatory effect on E1S formation in ER+ cells over the range of
Na+/K+ ratios examined. These results have also revealed that the
extent of stimulation or inhibition is influenced by the relative
concentration of Na+/K+ cations. Intriguingly, a significant recip-
rocal relationship was found between the ability of BCF to inhibit
E1S hydrolysis in ER+ cells while stimulating it in ER– cells.
Previous investigations have found that BCF can stimulate the
reduction of oestrone to oestradiol (E2DHI activity) in MCF-7
cells and aromatase activity in cultured breast fibroblasts (Lai et al,
1990b; Reed et al, 1993). The cytokine IL-6 was identified as a
major factor in BCF that could regulate aromatase activity (Reed
et al, 1992). IL-6 also stimulated E2DHI activity in MCF-7 cells
(Duncan et al, 1994b). High concentrations of IL-6 are present in
BCF with significantly higher levels present in Type II cyst fluids.
IL-6 can also stimulate E1-STS in MCF-7 breast cancer cells
(Purohit et al, 1999). In the present study, the BCF with the highest
Na+/K+ ratio was the only sample to moderately increase, rather
than inhibit, E1-STS activity in MCF-7 cells. 
Steroid sulphate concentrations (e.g. dehydroepiandrosterone
sulphate and E1S) can be very high in BCF and much higher than
the levels of these conjugates in blood (Lai et al, 1990b). Steroid
sulphate levels are higher in Type I BCF and they can act as
competitive inhibitors of E1-STS. However, the inhibition of E1-
STS activity by BCF detected in the present study is unlikely to be
due to the presence of steroid sulphates. After treating cells with
BCF, cells were washed with PBS before assaying for E1-STS
activity. Any steroid sulphates present in the medium would be
removed at this step. Inhibition of steroid sulphatase activity in
epithelial cells lining cysts, by factors present in BCF, may offer a
possible explanation as to why such high steroid sulphate levels
are present in cyst fluid.
The most striking finding of the present study was the signifi-
cantly greater stimulation of E1S formation by BCF from British
women in ER+ cancer cells. The relative roles of the enzymes
involved in E1S formation or hydrolysis with regard to the develop-
ment of breast cancer is controversial. There is evidence that the
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Figure 3 Effect of breast cyst fluid from British (closed circles) or Hungarian (open circles) women on oestrone sulphate formation in: (A) MCF-7 or (B) MDA-
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ability to sulphate oestrogens (and therefore inactivate them) is
lower in malignant than normal breast epithelium (Wild et al, 1991).
Based on this observation, Anderson and Howell have postulated
that sulphation is one of the means by which normal epithelial cells
limit their exposure to oestrogens (Anderson and Howell, 1995). An
alternative view is that the high blood and tissue concentrations of
E1S acts as a storage form of oestrogens that can be made available
by the action of E1-STS (Purohit et al, 1996).
In the present study the ratios of E1S formation to hydrolysis in
untreated ER+ and ER– cells were 4.1 and 0.4 respectively. On
treatment with BCF the ratio increased to 11.9 in MCF-7 cells
while decreasing to 0.14 in MDA-MB-231 cells. It would appear,
therefore, that there are fundamental differences in the way that
ER+ and ER– breast cancer cells regulate E1S formation and
hydrolysis. One possible explanation for these findings might be
that ER+ cells need a supply of oestrogen. By stimulating E1S
formation this would ensure that the cells had a stored form of
oestrogen that can be reactivated by E1-STS. E1S is a polar steroid
conjugate and, as such, would be unable to diffuse out of cells. In
contrast, ER– MDA-MB-231 cells have no requirement for
oestrogen. Hydrolysis of any oestrone formed would ensure that
the unconjugated, lipid soluble steroid could rapidly leave the cell.
Some preliminary experiments were carried out in an attempt to
characterize the nature of the factor(s) present in BCF that can
modulate E1S formation or hydrolysis. Part of the activity had a
molecular weight < 3 kDa. This would be compatible with factors
such as steroids or peptides. In addition, part had an apparent
molecular weight > 10 kDa which could be due either to large
molecules, such as cytokines, or to binding of a smaller factor such
as a steroid to high molecular weight proteins, since the separation
was not carried out under denaturing conditions. As the activity
did not bind to the anion ion-exchange column it is unlikely to be
due to a conjugated steroid such as a sulphate. However, the partial
binding to the cation exchange column suggests a possible net
positive charge at pH 7.4. The relative lack of binding to the
hydrophobic columns argues against the activity being an unconju-
gated steroid. While these are preliminary observations they are
consistent with one of the inhibitory factors in BCF being a small,
net positively charged peptide. Factors present in BCF with mole-
cular weights < 3 kDa or > 30 kDa have previously been shown to
stimulate E2DHI activity in MCF-7 breast cancer cells (Lai et al,
1990b).
In summary, the results from this investigation have revealed
that BCF can modulate the formation and hydrolysis of E1S in
breast cancer cells. How the ER status of cancer cells influences
whether the cells predominantly form or hydrolyse E1S remains to
be elucidated. As inhibitors of E1-STS may be of therapeutic value
the identification of factors in BCF that inhibit the activity of this
enzyme could lead to the development of novel enzyme inhibitors.
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